Pepper Hamilton LLP has snagged John F. Brenner from McCarter & English LLP and added him as a partner in its health effects litigation practice.
In a blow to the tobacco industry, the United States' highest court has declined to hear an appeal of a Florida state court’s ruling last year allowing more than half a million smokers to bring new cases against a group of tobacco companies following its rejection of a $145 billion jury verdict in a long-running class action lawsuit.
A group of pharmaceutical companies wants a court to summarily dismiss a consumer class action over its head lice medications on grounds that the claims are preempted by federal laws governing the labeling of over-the-counter drugs.
Officials in seven New York towns have called on a Manhattan federal court judge to remand their water-contamination cases against a group of major oil companies back to state court.
A group claiming to have suffered asbestos-related injuries after exposure to products manufactured by former Pfizer Inc. subsidiary Quigley Co. has slammed the company's moves to keep its “absentee” leader, Paul A. Street, at the helm.
The millions of patients that enroll in clinical trials for experimental drugs and medical devices each year are rarely watched over or protected by the U.S. Food and Drug Administration, a federal investigator has found.
Concerned after a toddler partially severed a finger, Lan Enterprises has decided to voluntarily recall thousands of doll strollers in an attempt to ward off more problems with the children's toy.
The U.S. Food and Drug Administration on Friday ordered that all prescription drugs that contain hydrocodone and have not received FDA approval be removed from the market.
A federal judge has granted class status to thousands of current and previous airplane owners who claim Lycoming Engines designed and built defective engine crankshafts that can cause a total loss of engine power as well as in-flight engine failures.
President George W. Bush signed legislation Thursday that renews the U.S. Food and Drug Administration's ability to charge fees for considering drugs for approval, alters the citizen petition process for generic drugs and strengthens drug safety.
Mattel Inc. asked a judge to halt a putative $5 million product-liability class action over alleged lead-tainted toys in New York federal court as the case awaits potential consolidation with ten others into a single piece of multidistrict litigation.
In what could be an alarming trend, another baby product has been recalled in the wake of an infant's death only days after the public received a warning about a series of cribs that are believed to have led to several fatalities as well.
Adding to a slew of attempts on Capitol Hill to address consumer concerns over food and product safety in the wake of numerous high-profile recalls, two senators have introduced legislation designed to pump up the power of regulators and to safeguard consumers from tainted goods.
A bankruptcy judge has approved Metabolife International Inc.’s Chapter 11 plan of liquidation, which calls for a $56 million fund to settle product liability suits over the diet pill ephedra.
The U.S. House of Representatives has greenlighted a controversial bill aimed at protecting workers from overexposure to the chemical diacetyl, a butter flavoring often used in microwave popcorn that has been linked to serious lung problems.
Only days after settling with a large class of consumers, Fifth Third Bancorp is facing a new named plaintiff in the ongoing class action brought against it by several banks over its role in a data security breach at TJX Companies Inc., one of the largest such breaches ever in the United States.
Less than a week after a massive crib recall, an Illinois mother has filed a potential class action lawsuit against manufacturer Simplicity Inc. and others, accusing the companies of negligence regarding the faulty baby product that allegedly lead to the death of at least one infant and possibly others.
Montana wants its suit over Zyprexa, the antipsychotic whose alleged dangers have led maker Eli Lilly & Co. to shell out billions to plaintiffs, separated from the consolidated federal action and sent back to state court.
AstraZeneca has asked for more time to produce documents in the Seroquel multidistrict litigation, saying that complying with U.K. and Swedish data-protection laws has delayed its ability to process and produce the documents.
A Pennsylvania state court has chucked a woman's lawsuit against Wyeth, Pfizer Inc. and Upjohn Co. over their controversial hormone replacement therapies, finding that she missed the two-year deadline to lodge her complaint.